A Highly Prevalent Polymorphism in the Core Region Impairs Quantification of Hepatitis B Virus (HBV) by the cobas TaqMan HBV Assay.

diagnosis hepatitis B virus plasma viral load underquantification viral surveillance

Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
24 08 2020
Historique:
received: 15 04 2020
accepted: 15 06 2020
pubmed: 17 7 2020
medline: 24 6 2021
entrez: 17 7 2020
Statut: epublish

Résumé

The high genetic variability of hepatitis B virus (HBV) can impair DNA quantification. Here, we investigate a major underquantification of HBV by the cobas TaqMan HBV assay (CTM; Roche). In France, between 2005 and 2017, HBV DNA was detected in 3,102 blood donations by use of the CTM (95% limit of detection [LOD

Identifiants

pubmed: 32669381
pii: JCM.00647-20
doi: 10.1128/JCM.00647-20
pmc: PMC7448625
pii:
doi:

Substances chimiques

DNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

J Med Virol. 2015 Mar;87(3):529-35
pubmed: 25170961
J Viral Hepat. 2007 Nov;14 Suppl 1:11-5
pubmed: 17958637
Diagn Microbiol Infect Dis. 2020 Feb;96(2):114946
pubmed: 31771903
BMC Biotechnol. 2008 Dec 04;8:91
pubmed: 19055817
Transfusion. 2010 Dec;50(12):2607-18
pubmed: 20553432
J Gen Virol. 2008 Feb;89(Pt 2):409-418
pubmed: 18198371
J Virol Methods. 2009 Aug;159(2):265-70
pubmed: 19406163
J Hepatol. 2017 Aug;67(2):370-398
pubmed: 28427875
J Clin Virol. 2009 Jul;45(3):232-6
pubmed: 19535286
Intervirology. 2014;57(3-4):141-50
pubmed: 25034481
Virol J. 2017 May 12;14(1):94
pubmed: 28494793
J Clin Microbiol. 2006 Jul;44(7):2587-9
pubmed: 16825388
J Clin Microbiol. 2010 Oct;48(10):3641-7
pubmed: 20720031
Hepatology. 2012 Aug;56(2):434-43
pubmed: 22271491
J Appl Lab Med. 2019 Nov;4(3):383-390
pubmed: 31659075
J Clin Microbiol. 2006 Oct;44(10):3600-7
pubmed: 17021089

Auteurs

Laure Boizeau (L)

National Institute of Blood Transfusion, Department of Blood-Borne Agents, National Reference Center for Infectious Risks in Transfusion, Paris, France.

Annabelle Servant-Delmas (A)

National Institute of Blood Transfusion, Department of Blood-Borne Agents, National Reference Center for Infectious Risks in Transfusion, Paris, France.

Alexandra Ducancelle (A)

Laboratory of Virology, Angers University Hospital, Angers, France.
HIFIH Laboratory, UPRES EA3859, SFR 4208, Angers University, Angers, France.

Stéphane Chevaliez (S)

Department of Virology, Henri Mondor Hospital, National Reference Center for Viral Hepatitis B, C and Delta, INSERM U955, Université Paris-Est, Créteil, France.

Vincent Thibault (V)

CHU Rennes, INSERM, EHESP, Institut de Recherche en Santé, Environnement et Travail (IRSET) - UMR_S 1085, Virology Unit Rennes, Rennes, France.

Syria Laperche (S)

National Institute of Blood Transfusion, Department of Blood-Borne Agents, National Reference Center for Infectious Risks in Transfusion, Paris, France slaperche@ints.fr pcappy@ints.fr.

Pierre Cappy (P)

National Institute of Blood Transfusion, Department of Blood-Borne Agents, National Reference Center for Infectious Risks in Transfusion, Paris, France slaperche@ints.fr pcappy@ints.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH